Literature DB >> 24316122

Sulfonamide inhibition studies of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis.

Daniela Vullo1, Sonia Del Prete2, Sameh M Osman3, Viviana De Luca2, Andrea Scozzafava1, Zeid Alothman3, Claudiu T Supuran4, Clemente Capasso5.   

Abstract

A carbonic anhydrase (CA, EC 4.2.1.1) denominated PgiCA, belonging to the γ-class, from the oral pathogenic bacteria Porphyromonas gingivalis, the main causative agent of periodontitis, was investigated for its inhibition profile with sulfonamides and one sulfamate. Dichlorophenamide, topiramate and many simple aromatic/heterocyclic sulfonamides were ineffective as PgiCA inhibitors whereas the best inhibition was observed with halogenosulfanilamides incorporating heavy halogens, 4-hydroxy- and 4-hydroxyalkyl-benzenesulfonamides, acetazolamide, methazolamide, zonisamide, indisulam, celecoxib, saccharin and hydrochlorothiazide (KIs in the range of 131-380nM). The inhibition profile of PgiCA was very different from that of CAM, hCA I and II or the β-CA from a protozoan parasite (Leishmania donovani chagasii). Identification of potent and possibly selective inhibitors of PgiCA may lead to pharmacological tools useful for understanding the physiological role(s) of this enzyme.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbonic anhydrase; Gamma-class enzyme; Porphyromonas gingivalis; Sulfonamide

Mesh:

Substances:

Year:  2013        PMID: 24316122     DOI: 10.1016/j.bmcl.2013.11.030

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Structure-Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae.

Authors:  Chad S Hewitt; Nader S Abutaleb; Ahmed E M Elhassanny; Alessio Nocentini; Xufeng Cao; Devon P Amos; Molly S Youse; Katrina J Holly; Anil Kumar Marapaka; Weiwei An; Jatinder Kaur; Aaron D Krabill; Ahmed Elkashif; Yehia Elgammal; Amanda L Graboski; Claudiu T Supuran; Mohamed N Seleem; Daniel P Flaherty
Journal:  ACS Infect Dis       Date:  2021-03-25       Impact factor: 5.084

2.  Structure-activity relationship studies for inhibitors for vancomycin-resistant Enterococcus and human carbonic anhydrases.

Authors:  Weiwei An; Katrina J Holly; Alessio Nocentini; Ryan D Imhoff; Chad S Hewitt; Nader S Abutaleb; Xufeng Cao; Mohamed N Seleem; Claudiu T Supuran; Daniel P Flaherty
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

3.  Sulfonamides with Potent Inhibitory Action and Selectivity against the α-Carbonic Anhydrase from Vibrio cholerae.

Authors:  Mariangela Ceruso; Sonia Del Prete; Zeid Alothman; Clemente Capasso; Claudiu T Supuran
Journal:  ACS Med Chem Lett       Date:  2014-05-23       Impact factor: 4.345

4.  A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects.

Authors:  Murat Bozdag; Melissa Pinard; Fabrizio Carta; Emanuela Masini; Andrea Scozzafava; Robert McKenna; Claudiu T Supuran
Journal:  J Med Chem       Date:  2014-11-10       Impact factor: 7.446

Review 5.  Carbonic Anhydrase from Porphyromonas Gingivalis as a Drug Target.

Authors:  Claudiu T Supuran; Clemente Capasso
Journal:  Pathogens       Date:  2017-07-15

6.  Comparison of the Sulfonamide Inhibition Profiles of the β- and γ-Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei.

Authors:  Daniela Vullo; Sonia Del Prete; Pietro Di Fonzo; Vincenzo Carginale; W Alexander Donald; Claudiu T Supuran; Clemente Capasso
Journal:  Molecules       Date:  2017-03-07       Impact factor: 4.411

7.  Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae.

Authors:  Nader S Abutaleb; Ahmed E M Elhassanny; Alessio Nocentini; Chad S Hewitt; Ahmed Elkashif; Bruce R Cooper; Claudiu T Supuran; Mohamed N Seleem; Daniel P Flaherty
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

8.  Ascaris lumbricoides β carbonic anhydrase: a potential target enzyme for treatment of ascariasis.

Authors:  Reza Zolfaghari Emameh; Marianne Kuuslahti; Daniela Vullo; Harlan R Barker; Claudiu T Supuran; Seppo Parkkila
Journal:  Parasit Vectors       Date:  2015-09-18       Impact factor: 3.876

9.  Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.

Authors:  P V Sri Ramya; Srinivas Angapelly; Andrea Angeli; Chander Singh Digwal; Mohammed Arifuddin; Bathini Nagendra Babu; Claudiu T Supuran; Ahmed Kamal
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

10.  Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with aromatic sulphonamides and clinically licenced drugs - a joint docking/molecular dynamics study.

Authors:  Alessandro Bonardi; Alessio Nocentini; Sameh Mohamed Osman; Fatmah Ali Alasmary; Tahani Mazyad Almutairi; Dalal Saied Abdullah; Paola Gratteri; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.